|Table of Contents|

[1] Duan Yanbing, Yu Jia, Liu Haifeng, et al. Determination of anthraquinone prodrugand its hydrolytically active compounds using RP-HPLC [J]. Journal of Southeast University (English Edition), 2009, 25 (1): 128-131. [doi:10.3969/j.issn.1003-7985.2009.01.027]
Copy

Determination of anthraquinone prodrugand its hydrolytically active compounds using RP-HPLC()
Share:

Journal of Southeast University (English Edition)[ISSN:1003-7985/CN:32-1325/N]

Volumn:
25
Issue:
2009 1
Page:
128-131
Research Field:
Biological Science and Medical Engineering
Publishing date:
2009-03-30

Info

Title:
Determination of anthraquinone prodrugand its hydrolytically active compounds using RP-HPLC
Author(s):
Duan Yanbing1 2 Yu Jia3 Liu Haifeng1 2 Ji Min1 2
1School of Chemistry and Chemical Engineering, Southeast University, Nanjing 210096, China
2Key Laboratory of Biomaterial and Technology, Suzhou Research Institute of Southeast University, Suzhou 215123, China
3College of Chengxian, Southeast University, Nanjing 210088, China
Keywords:
high-performance liquid chromatography(HPLC) quantitative analysis anthraquinone prodrug active components
PACS:
R917
DOI:
10.3969/j.issn.1003-7985.2009.01.027
Abstract:
In order to study the hydrolytic characterization of an anti-inflammatory prodrug(RI-1)in vitro, an effective, accurate and reliable method for the simultaneous determination of the prodrug and its two hydrolytic active compounds is developed using reverse phase high-performance liquid chromatography(RP-HPLC).The chromatographic separation is performed on an ODS-2 C18 column(250 mm×4.6 mm, 5.0 μm particle size)with a simple elution program.The mobile phase is V(methanol)∶V(0.1%phosphoric acid solution)=90∶10(adjust pH to 2.3).A wavelength of 225 nm and a mobile phase flow rate of 1.0 mL/min are utilized for the quantitative analysis.Excellent linear behaviors over the investigated concentration ranges are observed with values of R2 higher than 0.999 for all the analytes.The validated method is successfully applied to the simultaneous determination of the prodrug and its active components can be used to detect hydrolytic characterization in vitro.

References:

[1] Wang D, Sima M, Mosley R, et al.Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers[J].Molecular Pharmaceutics, 2006, 3(6):717-725.
[2] Dharap S, Wang Y, Chandna P, et al.Tumor-spectific targeting of an anticancer drug delivery system by LHRH peptide[J].Proceedings of National Academy of Sciences of the United States of America, 2005, 102(36):12962-12967.
[3] Kumpulainen H, Jarvinen T, Mannila A, et al.Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol[J].European Journal of Pharmaceutical Sciences, 2008 34(2/3):110-117.
[4] Rotem E, Sharon E, Bernard A, et al.Chemotherapeutic bone-targeted biophosphonate prodrugs with hydrolytic mode of activation [J].Bioorganic & Medicinal Chemistry Letters, 2008, 18(2):816-820.
[5] Itokawa H, Morris-Natschke Susan L, Akiyama T, et al.Plant-derived natural product research aimed at new drug discovery [J].Journal of Natural Medicines, 2008, 62(3):263-280.
[6] Tamuraa T, Shiraia T, Kosakaa N, et al.Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption[J].European Journal of Pharmacology, 2002, 448(1):81-87.
[7] Gonnot V, Tisserand S, Nicolas M, et al.Total synthesis of rhein and diacerhein via a directed ortho metalation of an aromatic substrate[J].Tetrahedron Letters, 2007, 48(40):7117-7119.
[8] Debord P, Louchahi K, Tod M, et al.Influence of renal function on the pharmacokinetics of diacerein after a single oral dose [J].European Journal of Drug Metabolism and Pharmacokinetics, 1994, 19(1):13-19.
[9] Tamura T, Kosaka N, Ishiwa J, et al.Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes [J].Osteoarthritis and Cartilage, 2001, 9(3):257-263.
[10] Perrin D.Binding of tetracyclines to bone [J].Nature, 1965, 208(11):787-788.
[11] Wang Y, Chen H, Wan Z, et al.Synthesis of a new series of bone affinity compounds [J].Chinese Chemical Letters, 2007, 17(3):310-312.

Memo

Memo:
Biographies: Duan Yanbing(1978—), male, graduate;Ji Min(corresponding author), female, doctor, professor, jimin@seu.edu.cn.
Citation: Duan Yanbing, Yu Jia, Liu Haifeng, et al.Determination of anthraquinone prodrug and its hydrolytically active compounds using RP-HPLC[J].Journal of Southeast University(English Edition), 2009, 25(1):128-131.
Last Update: 2009-03-20